RIO DE JANEIRO, BRAZIL - Overcrowded hospitals. Long hospital stays. Strained health systems. Intubated patients. Pictures that have been repeated around the globe since the beginning of the Covid-19 pandemic, caused by the coronavirus (Sars-CoV-2).
This scenario has also favored the proliferation of antibiotic-resistant bacteria. The number of superbacteria identified from Brazil has almost quadrupled in this period.
The data are from the Hospital Infection Research Laboratory of the Oswaldo Cruz Institute (IOC/Fiocruz). In 2019, the laboratory, part of the Analytical Sub-network of Microbial Resistance in Health Services (Sub-network RM) of the National Health . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here